Skip to main content
OpenTrials
Completed

NCT Number: NCT03702595

Effects of a Stretching Protocol in Patients With Hip Osteoarthritis

Hip osteoarthritis (OA) is one of the most prevalent chronic disease in the world. Clinical guidelines recommend non-pharmacological conservative treatments for the management of OA. Hip flexors seems to play an important role in the development of hip OA but there is no published studies evaluating the results of a stretching protocol of hip flexors in hip OA patients.

The objective of this trial is to evaluate if a stretching protocol of hip flexors is more effective in symptoms, functional capacity , range of motion, strength, muscular length, pain threshold and anxiety and depression compared to control.

For this purpose the investigators conduct a single-group, pretest-posttest clinical trial.The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence.

The variables are measured at the beginning and at the end of treatment of the control phase, and at the end of the stretching protocol phase.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hip Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Osteoarthritis Osteoarthritis, Hip Rheumatic Diseases

Age range

50 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sandra Jiménez del Barrio, Soria, Spain

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed medically with a X-Ray test
  • American College of Rheumatology Criteria

Exclusion criteria

  • Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
  • Vascular or neurological disease.
  • Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
  • Grade IV in Kellgren and Laurence Scale

Treatment and study plan

Hip flexors stretching protocol

Other

Stretching protocol of rectus femoris, vastus lateralis and iliopsoas according to Kaltenborn- Evjenth Orthopaedic Manual Therapy Concept (OMT)

Primary outcomes

  1. Changes from baseline in pain intensity

    Time frame: 3 weeks

    Visual Analogic Scale

Secondary outcomes

  1. Functional Capacity

    Time frame: 3 weeks

    The investigators measure the functional capacity with Timed Up and Go test (TUG)

  2. WOMAC questionnaire

    Time frame: 3 weeks

    WOMAC questionnaire

  3. Hip Range of Motion

    Time frame: 3 weeks

    Digital inclinometer according to Pua et al., 2008

  4. Muscular strength

    Time frame: 3 weeks

    The investigators measure the hip strength with a hand held dynamometer (Lafayette)

  5. Muscular length

    Time frame: 3 weeks

    The investigators measure the muscular length with an inclinometer

  6. Pressure Pain threshold

    Time frame: 3 weeks

    Pressure algometry measured by digital algometer

  7. Anxiety and Depression

    Time frame: 3 weeks

    Hospital Anxiety and Depression Scale (HADS)

Sponsors and collaborators

Lead sponsor

Universidad de Zaragoza

Other

Collaborators

  • University of Valladolid

Registry information

Official study title

Effects of a Stretching Protocol of Hip Flexors in Patients With Mild to Moderate Hip Osteoarthritis

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Oct 11, 2018
Registry last updated
Jan 21, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.